(Q45529367)

English

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr).

scientific article published on 31 December 2004

In more languages
default for all languages
No label defined

No description defined

Statements

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr). (English)
Cedrik M Britten
Burkhard Schmidt

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit